In a 4-3 ruling, the Missouri Supreme Court rejected a public nuisance claim brought against former lead paint manufacturers by the City of St. Louis, holding that the City’s inability to identify the defendants that supplied…
Hollingsworth LLP will co-sponsor the ABA Section of Dispute Resolution Spring Conference, “ADR in Bloom: Politics and Collaboration in the Nation’s Capital,” on April 26, 2007, at the Omni Shoreham hotel in Washington, DC. Joe Hollingsworth…
On November 16, 2006, the U.S. Court of Appeals for the Federal Circuit affirmed the contract liability of the United States to the firm’s client, the Caroline Hunt Trust Estate (“CHTE”) of Dallas, Texas. The appellate…
In 2005, the U.S. Court of Appeals for the Eleventh Circuit issued its opinion vacating the judgment of the trial court and erasing an $18 million lost profits award against the Firm’s client, General Electric. GE…
The National Law Journal selected Hollingsworth LLP three times in seven years for its Top Ten Defense Wins list, including for its success in Crowson v. Davol, a major medical device trial in 2004. This complex…
In 2005, the U.S. Court of Federal Claims (“CFC”) issued its decision in the Winstar-related case, Caroline Hunt Trust Estate v. United States, a breach of contract action that was vigorously contested by the government both as…
The U.S. District Court for the District of New Mexico issued its 67-page final summary judgment opinion dismissing the State of New Mexico’s natural resource damages claims against the Firm’s client General Electric and other defendants…
Joe Hollingsworth, national trial and appellate counsel for Novartis Pharmaceuticals Corp. in the Parlodel litigation, is featured in a supplement to The American Lawyer and Corporate Counsel magazines, “The Future of Litigation.” The article, “Inexact Science”…
The U.S. Court of Appeals for the Eleventh Circuit unanimously affirmed the grant of summary judgment to client, Novartis Pharmaceuticals in Rider/Siharath v. Sandoz Pharm. Corp., 131 F. Supp. 2d 1347 (N.D. Ga. 2001). This decision…
In March 2000, the U.S. District Court for the Western District of Oklahoma entered summary judgment for Sandoz Pharmaceuticals Corporation, holding that the plaintiff’s proffered expert testimony that Parlodel caused her stroke was not scientifically reliable…
Following a two-day evidentiary Daubert hearing in Caraker v. Sandoz Pharm. Corp., 172 F. Supp. 2d 1046 (S.D. Ill. 2001), Judge J. Phil Gilbert granted Firm client Sandoz’s motion to exclude expert testimony of plaintiffs’ expert witnesses…
In a unanimous decision, the 8th Circuit affirmed the grant of summary judgment to Novartis in Glastetter v. Novartis Pharmaceuticals Corp., 252 F.3d 986 (8th Cir. 2001). This significant Daubert decision and the decision below have…
March 19, 2001by Emily Heller For litigators who defend, winning summary judgment is about as good as it gets. To many, it’s even more satisfying than a favorable jury verdict because it avoids the expense and…
The U.S. District Court for the Northern District of Georgia issued a 69-page Daubert opinion in favor of our client in Rider/Siharath v. Sandoz Pharmaceuticals Corp., 131 F. Supp. 2d 1347 (N.D. Ga. 2001). Among the…
